Who We Are
Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic neuromuscular and neurological diseases.
Learn More-
-
Our Pipeline
Advancing transformative therapies to treat neuromuscular and neurological diseases
Learn More
-
Our Community
Committed to changing the treatment of people living with neuromuscular and neurological diseases
Learn More
